The DOI matches its Crossref record; 34 of the 35 references it cites were found in a registry or an index.
Effects of Angiotensin II Infusion on the Expression and Function of NAD(P)H Oxidase and Components of Nitric Oxide/cGMP Signaling
Abstract
Angiotensin II infusion causes endothelial dysfunction by increasing NAD(P)H oxidase-mediated vascular superoxide production. However, it remains to be elucidated how in vivo angiotensin II treatment may alter the expression of the gp91 phox isoforms and the endothelial nitric oxide synthase (NOS III) and subsequent signaling events and whether, in addition to the NAD(P)H oxidase, NOS III contributes to vascular superoxide formation. We therefore studied the influence of in vivo angiotensin II treatment (7 days) in rats on endothelial function and on the expression of the NAD(P)H oxidase subunits p22 phox , nox1, nox4, and gp91 phox and NOS III. Further analysis included the expression of NO-downstream targets, the soluble guanylyl cyclase (sGC), the cGMP-dependent protein kinase I (cGK-I), and the expression and phosphorylation of the vasodilator-stimulated phosphoprotein (VASP) at Ser239 (P-VASP). Angiotensin II caused endothelial dysfunction and increased vascular superoxide. Likewise, we found an increase in vascular protein kinase C (PKC) activity, in the expression of nox1 (6- to 7-fold), gp91 phox (3-fold), p22 phox (3-fold), NOS III mRNA, and protein. NOS-inhibition with N G -nitro- l -arginine decreased superoxide in vessels from angiotensin II-treated animals, compatible with NOS-uncoupling. Vascular NO assessed with electron paramagnetic resonance was markedly reduced. Likewise, a decrease in sGC-expression and P-VASP levels was found. In vivo PKC-inhibition with chelerythrine reduced angiotensin II-induced superoxide production and markedly inhibited upregulation of NAD(P)H oxidase subunits. We therefore conclude that angiotensin II-induced increases in the activity and the expression of NAD(P)H oxidase are at least in part PKC-dependent. NADPH oxidase-induced superoxide production may trigger NOS III uncoupling, leading to impaired NO/cGMP signaling and to endothelial dysfunction in this animal model. The full text of this article is available at http://www.circresaha.org.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“NOX2 expression has been also reported in other cell types including endothelial cells and adventitial fibroblasts (376, 382, 657, 714, 715, 736, 876) (FIGURE 9, Table 5).”
From Sources of Vascular Nitric Oxide and Reactive Oxygen Species and Their Regulation (2019) · cites this paper as [657]
Citations
Cites
Single-Step Method of RNA Isolation by Acid Guanidinium Thiocyanate–Phenol–Chloroform Extraction
Chomczynski, P., & Sacchi, N. (1987) · Analytical Biochemistry · doi:10.1006/abio.1987.9999 · Cited by 65,515
Angiotensin II stimulates NADH and NADPH oxidase activity in cultured vascular smooth muscle cells.
Griendling, K. K., Minieri, C. A., Ollerenshaw, J. D., & Alexander, R. W. (1994) · Circulation Research · doi:10.1161/01.res.74.6.1141 · Cited by 2,735
Self-citationRajagopalan, S., Kurz, S. D., Münzel, T. F., Tarpey, M. M., Freeman, B. Α., Griendling, K. K., & Harrison, D. G. (1996) · Journal of Clinical Investigation · doi:10.1172/jci118623 · Cited by 2,467
Self-citationBABIOR, B. M. (1999) · Blood · doi:10.1182/blood.v93.5.1464 · Cited by 2,147
Superoxide generation by endothelial nitric oxide synthase: The influence of cofactors
Vásquez-Vivar, J., Kalyanaraman, B., Martásek, P., Hogg, N., Masters, B. S. S., Karoui, H., Tordo, P., & Pritchard, K. A. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.16.9220 · Cited by 1,484
Mechanisms Underlying Endothelial Dysfunction in Diabetes Mellitus
Hink, U., Li, H., Mollnau, H., Oelze, M., Matheis, E., Hartmann, M., Skatchkov, M. P., Thaiss, F., Stahl, R. A. K., Warnholtz, A., et al. (2001) · Circulation Research · doi:10.1161/01.res.88.2.e14 · Cited by 1,191
Self-citationLassègue, B., Sorescu, D., Szöcs, K., Yin, Q., Akers, M., Zhang, Y., Grant, S. L., Lambeth, J. D., & Griendling, K. K. (2001) · Circulation Research · doi:10.1161/hh0901.090299 · Cited by 839
Self-citationUshio‐Fukai, M., Zafari, A. M., Fukui, T., Ishizaka, N., & Griendling, K. K. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.38.23317 · Cited by 766
Self-citationLaursen, J. B., Somers, M., Kurz, S., McCann, L., Warnholtz, A., Freeman, B. A., Tarpey, M., Fukai, T., & Harrison, D. G. (2001) · Circulation · doi:10.1161/01.cir.103.9.1282 · Cited by 721
Superoxide Generation from Endothelial Nitric-oxide Synthase
Xia, Y., Tsai, A.-L., Berka, V., & Zweier, J. L. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.40.25804 · Cited by 705
Research works printed but not linked: 16
- 10.1161/res.74.6.8187280 · DOI
- 10.1161/res.80.1.45 · DOI
- 10.1161/hyp.32.2.331 · DOI
- 10.1161/res.87.1.26 · DOI
- 10.1161/res.88.9.888 · DOI
- 10.1161/res.87.11.999 · DOI
- 10.1161/res.88.2.e14 · DOI
- 10.1161/circ.96.3.984 · DOI
- 10.1161/res.86.1.e7 · DOI
- 10.1161/circ.103.17.2188 · DOI
- 10.1016/0003-2697(87)90021-2 · DOI
- 10.1161/res.86.3.347 · DOI
- 10.1161/res.77.3.510 · DOI
- 10.1161/circ.103.9.1282 · DOI
- Abel K, Lingnau A, Niebuhr K, Wehland J, Walter U. Monoclonal antibodies against the focal adhesion protein VASP revealing epitopes involved in the interaction with two VASP binding proteins and VASP phosphorylation. Eur J Cell Biol. 1996; 69 (suppl 42): 39a.Abstract.
- 10.1161/res.85.6.534 · DOI
Cited by
Sorted by citations
Items 101–200 of 669
Wind, S., Beuerlein, K., Armitage, M. E., Taye, A., Kumar, A. H. S., Janowitz, D., Neff, C., Shah, A. M., Wingler, K., & Schmidt, H. H. H. W. (2010) · Hypertension · doi:10.1161/hypertensionaha.109.149187 · Cited by 181
Heart Failure With Preserved Ejection Fraction
Loffredo, F. S., Nikolova, A., Pancoast, J. R., & Lee, R. T. (2014) · Circulation Research · doi:10.1161/circresaha.115.302929 · Cited by 184
SARR, M., Chataigneau, M., MARTINS, S., Schott, C., Bedoui, J. E., Oak, M., Müller, B., Chataigneau, T., & Schini‐Kerth, V. B. (2006) · Cardiovascular Research · doi:10.1016/j.cardiores.2006.05.022 · Cited by 189
Dikalova, A. E., Góngora, M. C., Harrison, D. G., Lambeth, J. D., Dikalov, S., & Griendling, K. K. (2010) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00242.2010 · Cited by 179
Self-citationLi, H., Witte, K. K., August, M., Brausch, I., Gödtel‐Armbrust, U., Habermeier, A., Closs, E. I., Oelze, M., Münzel, T. F., & Förstermann, U. (2006) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2006.01.071 · Cited by 181
Self-citationProatherosclerotic Mechanisms Involving Protein Kinase C in Diabetes and Insulin Resistance
Rask‐Madsen, C., & King, G. L. (2005) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000155325.41507.e0 · Cited by 176
Functional Interplay Between Angiotensin II and Nitric Oxide
Chen, Y., Kim, D. S., Aizawa, T., & Berk, B. C. (2003) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000046231.17365.9d · Cited by 176
Rey, F. E., & Pagano, P. J. (2002) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000043452.30772.18 · Cited by 177
Kröller‐Schön, S., Knorr, M., Hausding, M., Oelze, M. W., Schuff, A., Schell, R., Sudowe, S., Scholz, A., Daub, S., Karbach, S. H., et al. (2012) · Cardiovascular Research · doi:10.1093/cvr/cvs246 · Cited by 177
Self-citationWallerath, T., Li, H., Gödtel‐Armbrust, U., Schwarz, P. M., & Förstermann, U. (2005) · Nitric Oxide · doi:10.1016/j.niox.2004.12.004 · Cited by 172
Self-citationGavrila, D., Li, W. G., McCormick, M. L., Thomas, M., Daugherty, A., Cassis, L. A., Miller, F. J., Oberley, L. W., Dellsperger, K. C., & Weintraub, N. L. (2005) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000172631.50972.0f · Cited by 172
From form to function: the role of Nox4 in the cardiovascular system
Chen, F., Haigh, S. B., Barman, S. A., & Fulton, D. J. (2012) · Frontiers in Physiology · doi:10.3389/fphys.2012.00412 · Cited by 181
Cambonie, G., Comte, B., Yzydorczyk, C., Ntimbane, T., Germain, N., Lê, N. L. O., Pladys, P., Gauthier, C., Lahaie, I., Abran, D., et al. (2006) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00227.2006 · Cited by 171
Daiber, A., Kröller-Schön, S., Frenis, K., Oelze, M., Kalinovic, S., Vujacic-Mirski, K., Kuntic, M., Jiménez, M. T. B., Helmstädter, J., Steven, S., et al. (2019) · Biofactors · doi:10.1002/biof.1506 · Cited by 155
Self-citationDoes Nitric Oxide Mediate the Vasodilator Activity of Nitroglycerin?
Kleschyov, A. L., Oelze, M. W., Daiber, A., Huang, Y., Mollnau, H., Schulz, E., Sydow, K., Fichtlscherer, B., Mülsch, A., & Münzel, T. F. (2003) · Circulation Research · doi:10.1161/01.res.0000100067.62876.50 · Cited by 161
Self-citationNitroso–Redox Balance in the Cardiovascular System
Hare, J. M. (2004) · New England Journal of Medicine · doi:10.1056/nejme048269 · Cited by 162
Tao, L., Liu, H., Gao, E., Teng, Z.-P., Lopez, B. L., Christopher, T. A., Ma, X., Batinic̈‐Haberle, I., Willette, R. N., Ohlstein, E. H., et al. (2003) · Circulation · doi:10.1161/01.cir.0000097003.49585.5e · Cited by 159
Wenzel, P., Kossmann, S., Münzel, T. F., & Daiber, A. (2017) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2017.01.027 · Cited by 161
Angiotensin II and oxidative stress
Hitomi, H., Kiyomoto, H., & Nishiyama, A. (2007) · Current Opinion in Cardiology · doi:10.1097/hco.0b013e3281532b53 · Cited by 162
Paravicini, T. M., Chrissobolis, S., Drummond, G. R., & Sobey, C. G. (2004) · Stroke · doi:10.1161/01.str.0000112974.37028.58 · Cited by 156
Hemnes, A. R., Zaiman, A., & Champion, H. C. (2007) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00245.2007 · Cited by 156
Heart failure with preserved ejection fraction in the elderly: scope of the problem
Upadhya, B., Taffet, G. E., Cheng, C. P., & Kitzman, D. W. (2015) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2015.02.025 · Cited by 160
Dual Effect of Ceramide on Human Endothelial Cells
Li, H., Junk, . C., Huwiler, A., Burkhardt, C., Wallerath, T., Pfeilschifter, J. M., & Förstermann, U. (2002) · Circulation · doi:10.1161/01.cir.0000035650.05921.50 · Cited by 156
Self-citationPathogenetic role of eNOS uncoupling in cardiopulmonary disorders
Gielis, J. F., Lin, J. Y., Wingler, K., Schil, P. E. V., Schmidt, H. H. H. W., & Moens, A. L. (2010) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2010.12.018 · Cited by 158
Flavonoids and Their Metabolites: Prevention in Cardiovascular Diseases and Diabetes
Zeka, K., Ruparelia, K. C., Arroo, R., Budriesi, R., & Micucci, M. (2017) · Diseases · doi:10.3390/diseases5030019 · Cited by 160
Bachschmid, M. M., Schildknecht, S., Matsui, R., Zee, R. S., Haeussler, D. J., Cohen, R. A., Pimental, D. R., & van der Loo, B. (2012) · Annals of Medicine · doi:10.3109/07853890.2011.645498 · Cited by 159
Förstermann, U. (2006) · Biological Chemistry · doi:10.1515/bc.2006.190 · Cited by 155
Therapeutic potential of nitric oxide donors in the prevention and treatment of atherosclerosis
Herman, A. G., & Moncada, S. (2005) · European Heart Journal · doi:10.1093/eurheartj/ehi333 · Cited by 156
Prevention of Atherosclerosis by Interference with the Vascular Nitric Oxide System
Li, H., & Förstermann, U. (2009) · Current Pharmaceutical Design · doi:10.2174/138161209789058002 · Cited by 154
Self-citationZinc and Redox Signaling: Perturbations Associated with Cardiovascular Disease and Diabetes Mellitus
Foster, M. J., & Samman, S. (2010) · Antioxidants and Redox Signaling · doi:10.1089/ars.2010.3111 · Cited by 149
Transportation Noise Pollution and Cardiovascular Health
Münzel, T. F., Molitor, M., Kuntić, M., Hahad, O., Röösli, M., Engelmann, N., Basner, M., Daiber, A., & Sørensen, M. (2024) · Circulation Research · doi:10.1161/circresaha.123.323584 · Cited by 156
NADPH Oxidase Inhibitors: New Antihypertensive Agents?
Williams, H. C., & Griendling, K. K. (2007) · Journal of Cardiovascular Pharmacology · doi:10.1097/fjc.0b013e318063e820 · Cited by 146
Self-citationRedox Control of Renal Function and Hypertension
Nistala, R., Whaley‐Connell, A. T., & Sowers, J. R. (2008) · Antioxidants and Redox Signaling · doi:10.1089/ars.2008.2034 · Cited by 147
20-Hydroxyeicosatetraenoic acid causes endothelial dysfunction via eNOS uncoupling
Cheng, J., Ou, J., Singh, H., Falck, J. R., Dubasi, N., Pritchard, K. A., & Schwartzman, M. L. (2007) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.01172.2007 · Cited by 145
The Role of Oxidative Stress in the Metabolic Syndrome
Whaley‐Connell, A. T., McCullough, P. A., & Sowers, J. R. (2011) · Reviews in Cardiovascular Medicine · doi:10.3909/ricm0555 · Cited by 146
Reactive oxygen species, Nox and angiotensin II in angiogenesis: implications for retinopathy
Wilkinson‐Berka, J. L., Rana, I., Armani, R., & Agrotis, A. (2013) · Clinical Science · doi:10.1042/cs20120212 · Cited by 141
Romero, M., Jiménez, R., Sánchez, M., López-Sepúlveda, R., Zarzuelo-Romero, M. J., O’Valle, F., Zarzuelo, A., Pérez‐Vizcaíno, F., & Duarte, J. (2008) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2008.03.007 · Cited by 142
NADPH oxidases and vascular remodeling in cardiovascular diseases
García‐Redondo, A. B., Aguado, A., Briones, A. M., & Salaíces, M. (2016) · Pharmacological Research · doi:10.1016/j.phrs.2016.10.015 · Cited by 139
Enhanced external counterpulsation for ischemic heart disease
Bonetti, P. O., Holmes, D. R., Lerman, A., & Barsness, G. W. (2003) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(03)00428-5 · Cited by 136
Angiotensin II blockade: a strategy to slow ageing by protecting mitochondria?
de Cavanagh, E. M. V., Inserra, F., & Ferder, L. (2010) · Cardiovascular Research · doi:10.1093/cvr/cvq285 · Cited by 139
Ferder, M., Inserra, F., Manucha, W. A., & Ferder, L. (2013) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00403.2011 · Cited by 138
Novel isoforms of NADPH oxidase in vascular physiology and pathophysiology
BENGTSSON, S. H. M., Gulluyan, L. M., Dusting, G. J., & Drummond, G. R. (2003) · Clinical and Experimental Pharmacology and Physiology · doi:10.1046/j.1440-1681.2003.03929.x · Cited by 136
NADPH oxidases as therapeutic targets in ischemic stroke
Kahles, T., & Brandes, R. P. (2012) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-012-1011-8 · Cited by 138
Hypertension, Nitric Oxide, Oxidants, and Dietary Plant Polyphenols
Galleano, M., Pecháňová, O., & Fraga, C. G. (2010) · Current Pharmaceutical Biotechnology · doi:10.2174/138920110793262114 · Cited by 133
Rolfe, B. E., Worth, N. F., WORLD, C., Campbell, J. H., & CAMPBELL, G. R. (2005) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2005.04.023 · Cited by 132
Simvastatin Therapy Normalizes Sympathetic Neural Control in Experimental Heart Failure
Gao, L., Wang, W., Li, Y., Schultz, H. D., Liu, D., Cornish, K. G., & Zucker, I. H. (2005) · Circulation · doi:10.1161/circulationaha.105.552174 · Cited by 130
Daiber, A., Kröller‐Schön, S., Oelze, M. W., Hahad, O., Li, H., Schulz, R., Steven, S., & Münzel, T. F. (2020) · Redox Biology · doi:10.1016/j.redox.2020.101506 · Cited by 136
Self-citationHoopes, S. L., Garcia, V. G., Edin, M. L., Schwartzman, M. L., & Zeldin, D. C. (2015) · Prostaglandins & Other Lipid Mediators · doi:10.1016/j.prostaglandins.2015.03.002 · Cited by 130
Oxidative Stress Promotes Blood Cell-Endothelial Cell Interactions in the Microcirculation
Cooper, D., Stokes, K. Y., Tailor, A., & Granger, D. N. (2002) · Cardiovascular Toxicology · doi:10.1007/s12012-002-0002-7 · Cited by 127
Role of Matrix Metalloproteinases in the Pathogenesis of Traumatic Brain Injury
Muneer, P. M. A., Pfister, B. J., Haorah, J., & Chandra, N. (2015) · Molecular Neurobiology · doi:10.1007/s12035-015-9520-8 · Cited by 132
Coppey, L. J., Davidson, E. P., Rinehart, T. W., Gellett, J. S., Oltman, C. L., Lund, D. D., & Yorek, M. A. (2006) · Diabetes · doi:10.2337/diabetes.55.02.06.db05-0885 · Cited by 127
From Mitochondria to Disease: Role of the Renin-Angiotensin System
de Cavanagh, E. M. V., Inserra, F., Ferder, M., & Ferder, L. (2007) · American Journal of Nephrology · doi:10.1159/000107757 · Cited by 124
Ceramide-induced activation of NADPH oxidase and endothelial dysfunction in small coronary arteries
Zhang, D. X., Zou, A.-P., & Li, P. (2003) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00697.2002 · Cited by 124
Differential effects of diabetes on the expression of the gp91phox homologues nox1 and nox4
Wendt, M. C., Daiber, A., Kleschyov, A. L., Mülsch, A., Sydow, K., Schulz, E., Chen, K., Keaney, J. F., Lassègue, B., Walter, U., et al. (2005) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2005.03.020 · Cited by 122
Self-citationReinventing the ACE inhibitors: some old and new implications of ACE inhibition
Hanif, K., Bid, H. K., & Konwar, R. (2009) · Hypertension Research · doi:10.1038/hr.2009.184 · Cited by 126
Chronic High Pressure-Induced Arterial Oxidative Stress
Ungvari, Z. I., Csiszár, A., Kaminski, P. M., Wolin, M. S., & Koller, Á. (2004) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)63290-7 · Cited by 122
Metformin in cardiovascular diabetology: a focused review of its impact on endothelial function
Ding, Y., Zhou, Y., Ling, P., Feng, X., Luo, S., Zheng, X., Little, P. J., Xu, S., & Weng, J. (2021) · Theranostics · doi:10.7150/thno.64706 · Cited by 121
Nox as a target for diabetic complications
Gorin, Y. C., & Block, K. L. (2013) · Clinical Science · doi:10.1042/cs20130065 · Cited by 122
Protective Effects of Short-Chain Fatty Acids on Endothelial Dysfunction Induced by Angiotensin II
Robles‐Vera, I., Toral, M., de la Visitación, N., Aguilera-Sánchez, N., Redondo, J. M., & Duarte, J. (2020) · Frontiers in Physiology · doi:10.3389/fphys.2020.00277 · Cited by 118
Szöcs, K. (2004) · PubMed · Cited by 117
de Cavanagh, E. M. V., Ferder, M., Inserra, F., & Ferder, L. (2009) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.01176.2008 · Cited by 117
Aktas, B., Utz, A. L., Hönig‐Liedl, P., Walter, U., & Geiger, J. (2003) · Stroke · doi:10.1161/01.str.0000056527.34434.59 · Cited by 116
Self-citationWenzel, P., Schulz, E., Oelze, M. W., Müller, J., Schuhmacher, S., Alhamdani, M. S. S., Debrezion, J., Hortmann, M., Reifenberg, K., Fleming, I., et al. (2008) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2008.05.009 · Cited by 115
Self-citationBirschmann, I., & Walter, U. (2004) · Acta Biochimica Polonica · doi:10.18388/abp.2004_3579 · Cited by 115
Self-citationSteven, S., Hausding, M., Kröller-Schön, S., Mader, M., Mikhed, Y., Stamm, P., Zinßius, E., Pfeffer, A., Welschof, P., Agdauletova, S., et al. (2015) · Basic Research in Cardiology · doi:10.1007/s00395-015-0465-x · Cited by 114
Self-citationKossmann, S., Hu, H., Steven, S., Schönfelder, T., Fraccarollo, D., Mikhed, Y., Brähler, M., Knorr, M., Brandt, M., Karbach, S. H., et al. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.m114.604231 · Cited by 116
Self-citationABSORB II randomized controlled trial
Diletti, R., Serruys, P. W. J. C., Farooq, V., Sudhir, K., Dorange, C., Miquel‐Hébert, K., Veldhof, S., Rapoza, R. R., Onuma, Y., García‐García, H. M., et al. (2012) · American Heart Journal · doi:10.1016/j.ahj.2012.08.010 · Cited by 113
A Role for NOX NADPH Oxidases in Alzheimer's Disease and Other Types of Dementia?
Zekry, D., Epperson, T. K., & Krause, K. (2003) · IUBMB Life · doi:10.1080/1521654031000153049 · Cited by 115
Reactive Oxygen Species and Endothelial Activation
Alom-Ruiz, S. P., Anilkumar, N. P., & Shah, A. M. (2008) · Antioxidants and Redox Signaling · doi:10.1089/ars.2007.2007 · Cited by 115
Angiotensin II and Oxidative Stress in the Failing Heart
Zablocki, D., & Sadoshima, J. (2012) · Antioxidants and Redox Signaling · doi:10.1089/ars.2012.4588 · Cited by 110
Perivascular Superoxide Anion Contributes to Impairment of Endothelium-Dependent Relaxation
Rey, F. E., Li, X.-C., Carretero, O. A., Garvin, J. L., & Pagano, P. J. (2002) · Circulation · doi:10.1161/01.cir.0000038108.71560.70 · Cited by 111
Oxidative stress-mediated effects of angiotensin II in the cardiovascular system
Wen, H. (2012) · World Journal of Hypertension · doi:10.5494/wjh.v2.i4.34 · Cited by 109
Li, H., Burkhardt, C., Heinrich, U., Brausch, I., Xia, N., & Förstermann, U. (2003) · Circulation · doi:10.1161/01.cir.0000066697.19571.af · Cited by 109
Self-citationNovel isoforms of NADPH-oxidase in cerebral vascular control
Miller, A. A., Drummond, G. R., & Sobey, C. G. (2006) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2006.02.005 · Cited by 110
Angiotensin II–Dependent Superoxide
Welch, W. J. (2008) · Hypertension · doi:10.1161/hypertensionaha.107.090472 · Cited by 111
Nyberg, M., Gliemann, L., Thaning, P., Hellsten, Y., & Mortensen, S. P. (2012) · The Journal of Physiology · doi:10.1113/jphysiol.2011.225136 · Cited by 108
Testosterone supplementation in aging men and women: possible impact on cardiovascular-renal disease
Reckelhoff, J. F., Yanes, L. L., Iliescu, R., Fortepiani, L. A., & Granger, J. P. (2005) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00034.2005 · Cited by 105
Lu, G., Huang, L., Zhang, X. L., Wang, S., Hong, Y., Hu, Z., & Geng, D. Y. (2011) · American Journal of Neuroradiology · doi:10.3174/ajnr.a2461 · Cited by 104
Weber, D. S., Ročić, P., Mellis, A. M., Laude, K. M., Lyle, A. N., Harrison, D. G., & Griendling, K. K. (2004) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00638.2004 · Cited by 106
Self-citationChen, J., Xiao, X., Chen, S., Zhang, C., Chen, J., Yi, D., Shenoy, V., Raizada, M. K., Zhao, B., & Chen, Y. (2012) · Hypertension · doi:10.1161/hypertensionaha.111.00202 · Cited by 102
Heme oxygenase: the key to renal function regulation
Abraham, N. G., Cao, J. J., Sacerdoti, D., Li, X., & Drummond, G. (2009) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.90449.2008 · Cited by 102
Melichar, V. O., Behr‐Roussel, D., Zabel, U., UTTENTHAL, L. O., Rodrigo, J., Rupin, A., Verbeuren, T. J., Kumar, A. H. S., & Schmidt, H. H. H. W. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0405509101 · Cited by 102
Ma, M., Gao, M., Guo, K.-M., Wang, M., Li, X., Zeng, X., Sun, L., Lv, X., Du, Y., Wang, G., et al. (2017) · Hypertension · doi:10.1161/hypertensionaha.116.08874 · Cited by 103
Oxidative Stress in Kidney Injury and Hypertension
Arendshorst, W. J., Vendrov, A. E., Kumar, N., Ganesh, S. K., & Madamanchi, N. R. (2024) · Antioxidants · doi:10.3390/antiox13121454 · Cited by 108
Gragasin, F. S., Xu, Y., Arenas, I. A., Kainth, N., & Davidge, S. T. (2003) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000047868.93732.b7 · Cited by 101
Hernanz, R., Briones, A. M., Salaíces, M., & Alonso, M. J. (2013) · Clinical Science · doi:10.1042/cs20120651 · Cited by 100
Fortuño, A., Oliván, S., Beloqui, Ó., José, G. S., Moreno, M. U., ez, J. D., & Zalba, G. (2004) · Journal of Hypertension · doi:10.1097/00004872-200411000-00020 · Cited by 99
Characteristics and function of cardiac mitochondrial nitric oxide synthase
Dedkova, E. N., & Blatter, L. A. (2008) · The Journal of Physiology · doi:10.1113/jphysiol.2008.165423 · Cited by 101
Wang, D., Chen, Y., Chabrashvili, T., Aslam, S., Borrego-Conde, L. J., Umans, J. G., & Wilcox, C. S. (2003) · Journal of the American Society of Nephrology · doi:10.1097/01.asn.0000090747.59919.d2 · Cited by 99
Nitric Oxide, NAD(P)H Oxidase, and Atherosclerosis
Müller, G. M., & Morawietz, H. (2009) · Antioxidants and Redox Signaling · doi:10.1089/ars.2008.2403 · Cited by 98
Targeting Nitric Oxide with Natural Derived Compounds as a Therapeutic Strategy in Vascular Diseases
Forte, M., Conti, V., Damato, A., Ambrosio, M., Puca, A. A., Sciarretta, S., Frati, G., Vecchione, C., & Carrizzo, A. (2016) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2016/7364138 · Cited by 100
Widder, J. D., Guzik, T. J., Mueller, C. F. H., Clempus, R. E., Schmidt, H. H. H. W., Dikalov, S., Griendling, K. K., Jones, D. P., & Harrison, D. G. (2007) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000259298.11129.a2 · Cited by 94
Self-citationThe role of 20-HETE in cardiovascular diseases and its risk factors
Waldman, M., Peterson, S. J., Arad, M., & Hochhauser, E. (2016) · Prostaglandins & Other Lipid Mediators · doi:10.1016/j.prostaglandins.2016.05.007 · Cited by 94
Tran, V., Silva, T. M. D., Sobey, C. G., Lim, K., Drummond, G. R., Vinh, A., & Jelinic, M. (2020) · Frontiers in Pharmacology · doi:10.3389/fphar.2020.00148 · Cited by 94
Hemodynamic and biochemical adaptations to vascular smooth muscle overexpression of p22phox in mice
Laude, K. M., Cai, H. “., Fink, B., Hoch, N. E., Weber, D. S., McCann, L. A., Kojda, G., Fukai, T., Schmidt, H. H. H. W., Dikalov, S., et al. (2004) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00637.2004 · Cited by 94
Self-citationElectron paramagnetic resonance (EPR) spin trapping of biological nitric oxide
Kleschyov, A. L., Wenzel, P., & Münzel, T. F. (2006) · Journal of Chromatography B · doi:10.1016/j.jchromb.2006.10.006 · Cited by 96
Self-citationThe Puzzle of Nitrate Tolerance
Gori, T., & Parker, J. D. (2002) · Circulation · doi:10.1161/01.cir.0000036742.52907.91 · Cited by 92
Thioredoxin and ventricular remodeling
Ago, T., & Sadoshima, J. (2006) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2006.08.006 · Cited by 92
Wohlfart, P., Xu, H., Endlich, A., Habermeier, A., Closs, E. I., Hübschle, T., Mang, C. F., Strobel, H., Suzuki, T. C., Kleinert, H., et al. (2008) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.107.128009 · Cited by 91
Self-citationKleinhenz, J., Kleinhenz, D. J., You, S., Ritzenthaler, J. D., Hansen, J. M., Archer, D. R., Sutliff, R. L., & Hart, C. M. (2009) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00148.2009 · Cited by 91
Metadata
- Authors
- Mollnau, H., Wendt, M., Szöcs, K., Lassègue, B., Schulz, E., Oelze, M., Li, H., Bodenschatz, M., August, M., Kleschyov, A. L., Tsilimingas, N., Walter, U., Förstermann, U., Meinertz, T., Griendling, K., & Münzel, T.
- Affiliations
- Emory University (US)
- From the Division of Cardiology (H.M., M.W., E.S., M.O., M.B., M.A., A.L.K., T. Meinertz., T. Münzel) and Cardiovascular Surgery (N.T.), University Hospital Eppendorf, Hamburg, Germany; the Department of Clinical Biochemistry and Pathobiochemistry (U.W.), University of Würzburg, Germany; the Department of Pharmacology (H.L., U.F.), Johannes Gutenberg University, Mainz, Germany; and the Department of Cardiology (K.S., B.L., K.G.), Emory University, Atlanta, Ga.
- Venue
- Circulation Research
- Published
- 2002-03-08
- Volume
- 90
- Issue
- 4
- Pages
- E58-65
- ISSN
- 0009-7330 (ISSN-L)
- 1524-4571
- OpenAlex
- W2114547396
- Cited by
- 676
- References
- 35
- Citations by year
- 2026: 5 · 2025: 4 · 2024: 9 · 2023: 15 · 2022: 10 · 2021: 13 · 2020: 20 · 2019: 14 · 2018: 15 · 2017: 24 · 2016: 21 · 2015: 29 · 2014: 26 · 2013: 25 · 2012: 38
- FWCI
- 32.37
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Circulation Research (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Deutsche Forschungsgemeinschaft
- Topics
- Health Sciences › Medicine › Physiology (medical) › Nitric Oxide and Endothelin Effects
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Renin-Angiotensin System Studies
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Redox biology and oxidative stress
- Keywords
- angiotensin II, NADPH oxidase, endothelial dysfunction, nitric oxide synthase uncoupling, nitric oxide/cGMP signaling, superoxide production, gp91phox, NOX1, NOX4, p22phox, soluble guanylate cyclase, cGMP-dependent protein kinase I, VASP phosphorylation, protein kinase C, chelerythrine, L-NNA
- MeSH terms
- Soluble Guanylyl Cyclase, NADPH Oxidase 1, NADPH Oxidase 2, NADPH Oxidase 4, Vasodilator-Stimulated Phosphoprotein, Angiotensin II, Animals, Aorta, Blood Pressure, Disease Models, Animal, Enzyme Activation, Cyclic GMP, Guanylate Cyclase, Infusions, Parenteral, Membrane Glycoproteins, Microfilament Proteins, NAD, NADH, NADPH Oxidoreductases, NADP, NADPH Dehydrogenase, Nitric Oxide, Phosphoproteins, Protein Kinase C, Superoxides, Vasodilation, Vasodilator Agents, Signal Transduction, Cell Adhesion Molecules, Rats, Wistar, Cyclic GMP-Dependent Protein Kinases, Receptors, Cytoplasmic and Nuclear, Nitric Oxide Synthase, NADPH Oxidases, Membrane Transport Proteins, Rats, Nitric Oxide Synthase Type III, Cyclic GMP-Dependent Protein Kinase Type I, In Vitro Techniques
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review